VION Biosciences Acquires Echelon Biosciences, a Leader in Specialty Lipids and Nanoparticles

VION Biosciences, a life science platform company specializing in specialty reagents for research, diagnostics, and drug discovery, has announced the acquisition of Echelon Biosciences, a Salt Lake City-based supplier known for its critical materials, including lipid-based excipients. This acquisition marks…

Read MoreVION Biosciences Acquires Echelon Biosciences, a Leader in Specialty Lipids and Nanoparticles

EMulate Therapeutics demonstrates immune checkpoint knockdown in a glioblastoma mouse model

EMulate Therapeutics, Inc. has announced that the Open Journal of Biophysics (OJBIPHY) will publish its manuscript, titled “Magnetic Field Emulations of Small Inhibitor RNA: Effects on Implanted GL261 Tumors in C57BL/6 Immune Competent Mice.” This study supports independent findings recently…

Read MoreEMulate Therapeutics demonstrates immune checkpoint knockdown in a glioblastoma mouse model

Innovo Therapeutics Reports Positive Phase 2 Results for INV-001 in Post-Thyroidectomy Scar Treatment

Innovo Therapeutics Inc. has announced promising results from its Phase 2 clinical trial for INV-001, an innovative treatment for post-thyroidectomy scars. The trial, conducted across four hospitals in Korea, including Severance Hospital in Seoul, involved 77 patients with thyroidectomy wounds…

Read MoreInnovo Therapeutics Reports Positive Phase 2 Results for INV-001 in Post-Thyroidectomy Scar Treatment

Carilion Clinic Enhances Cardiac Care with New Philips Innovations at Crystal Spring Tower

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Carilion Clinic, a nonprofit healthcare provider serving over one million people in Virginia and West Virginia, have announced a major collaboration. Carilion Clinic will implement Philips’ comprehensive…

Read MoreCarilion Clinic Enhances Cardiac Care with New Philips Innovations at Crystal Spring Tower